Search

Your search keyword '"Grayson, Peter C."' showing total 543 results

Search Constraints

Start Over You searched for: Author "Grayson, Peter C." Remove constraint Author: "Grayson, Peter C."
543 results on '"Grayson, Peter C."'

Search Results

1. Automated Plaque Detection and Agatston Score Estimation on Non-Contrast CT Scans: A Multicenter Study

3. Venous and arterial thrombosis in patients with VEXAS syndrome

5. Takayasu’s Arteritis

6. Early activation of inflammatory pathways in UBA1-mutated hematopoietic stem and progenitor cells in VEXAS

7. Spectrum of clonal hematopoiesis in VEXAS syndrome

12. Neutrophil activation in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis and large-vessel vasculitis

13. Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis

14. Clinical Characteristics and Outcomes of Polyarteritis Nodosa: An International Study.

16. ACR Appropriateness Criteria® Noncerebral Vasculitis

17. Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1

18. Development of the Takayasu's Arteritis Integrated Disease Activity Index

19. Clonal haematopoiesis across the age spectrum of vasculitis patients with Takayasu’s arteritis, ANCA-associated vasculitis and giant cell arteritis

25. Large-vessel vasculitis

27. Mitochondrial-mediated inflammation and platelet activation in giant cell arteritis

29. Identification of new risk loci shared across systemic vasculitides points towards potential target genes for drug repurposing

33. Neutrophil extracellular trap formation in anti-neutrophil cytoplasmic antibody-associated and large-vessel vasculitis

34. Risk of relapse of ANCA-associated vasculitis among patients homozygous for the proteinase 3 gene Val119Ile polymorphism

35. Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica

36. Identification of new risk loci shared across systemic vasculitides points towards potential target genes for drug repurposing

38. Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical Population

42. Clonal Hematopoiesis in a Broad Age Spectrum of Systemic Vasculitis

43. Eosinophilia in Vexas Syndrome: Expanding Hematologic Phenotype

44. DNMT3A/TET2 Mutant Clonal Hematopoiesis in Vexas Syndrome Results in DNA Hypomethylation and Transcriptional Activation of WT1 and MPL Oncogenic Pathways

45. Clonal Hematopoiesis in Vexas Syndrome

46. Thrombotic Manifestations in Patients with Vexas Syndrome

47. 2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis

48. 2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis

49. Reply.

50. Longitudinal Characterization of Vascular Inflammation and Disease Activity in Takayasu Arteritis and Giant Cell Arteritis: A Single‐Center Prospective Study.

Catalog

Books, media, physical & digital resources